LDN Social Media
Get connected with us on social networks
New study spotlights therapeutic solution for long COVID fatigue.
Author: Eleanor Garth | Published on: April 9, 2024 | Last updated: April 10, 2024
AgelessRx researchers suggest LDN and NAD+ not only address long COVID symptoms, but target the root cause of its pathology.
A recent trial suggested that combining NAD+ with Low Dose Naltrexone (LDN) could improve fatigue symptoms and quality of life in patients with persistent fatigue after COVID-19 – also known as long COVID [1]. These results not only signify progress in combating long COVID but also represent an important step in addressing the underlying causes of the debilitating condition which is currently affecting nearly 18 million people living in the US [2].
To read the whole article click here https://longevity.technology/news/new-study-spotlights-therapeutic-solution-for-long-covid-fatigue/